# DANOCRINE
> **NDA017557** · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1976-06-21
## Drug
- **FDA Application Number:** NDA017557
- **Application type:** New Drug Application
- **Brand name:** DANOCRINE
- **Generic name:** Danazol
- **Active ingredients:** DANAZOL
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANOFI AVENTIS US
- **First approval:** 1976-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017557)
---
*AI Analytics · CC0 1.0*